From "Mega-invasive" to "Minimally invasive"-Progress in the treatment of minimally invasive valve disease
-
摘要: 瓣膜性心脏病(valvular heart disease，VHD)的人群患病率在逐年增加，迄今为止手术治疗是其最为有效的治疗手段。随着对疾病发病机制认识的不断深入，以及材料和技术的不断进步，外科手术和介入治疗方式也在不断优化，不同的手术方式使VHD患者有着更加多元化的治疗选择，这就要求心脏外科医生应当根据患者情况结合现有最新的研究证据制定个体化最佳治疗方案，包括瓣膜疾病终身管理策略。Abstract: The prevalence of valvular heart disease (VHD) is increasing year by year, and surgery is by far the most effective treatment. With deeper cognition about mechanisms of valve disease and the continuous progress of materials and technology, surgical procedures and interventional procedures are also being optimized. Different minimally invasive surgical methods and transcatheter theraputic strategy make the treatment of patients with VHD more diversified options, which requires cardiac surgeons to develop a personalized treatment schemes or even life-long management strategies for valvular disease according to individual patient's special condition combined with the latest theraputic evidence.
-
-
[1] Coffey S, Roberts-Thomson R, Brown A, et al. Global epidemiology of valvular heart disease[J]. Nat Rev Cardiol, 2021, 18(12): 853-864. doi: 10.1038/s41569-021-00570-z
[2] 李光, 杨昭, 刘硕, 等. 经右侧小切口开胸手术治疗多瓣膜病的研究[J]. 心肺血管病杂志, 2022, 41(7): 792-796. doi: 10.3969/j.issn.1007-5062.2022.07.017
[3] Akowuah EF, Maier RH, Hancock HC, et al. Minithoracotomy vs conventional sternotomy for mitral valve repair: a randomized clinical trial[J]. JAMA, 2023, 329(22): 1957-1966. doi: 10.1001/jama.2023.7800
[4] Bonacchi M, Dokollari A, Parise O, et al. Ministernotomy compared with right anterior minithoracotomy for aortic valve surgery[J]. J Thoracic Cardiovasc Surg, 2023, 165(3): 1022-1032. e2. doi: 10.1016/j.jtcvs.2021.03.125
[5] 马云鹏, 齐胤尊, 刘瑞生. 胸腔镜辅助下右胸小切口行二尖瓣成形术同期三尖瓣成形术的疗效及安全性研究[J]. 中国现代医学杂志, 2022, 32(14): 77-82. doi: 10.3969/j.issn.1005-8982.2022.14.014
[6] Yilmaz A, van Genechten S, Claessens J, et al. A totally endoscopic approach for aortic valve surgery[J]. Euro J Cardiothorac Surg, 2022, 62(6): ezac467. doi: 10.1093/ejcts/ezac467
[7] 陈波, 戴小福, 王涛, 等. 双孔法全胸腔镜主动脉瓣-二尖瓣双瓣置换术的技术细节探讨及早期结果分析[J]. 中华外科杂志, 2024, 62(5): 400-405. doi: 10.3760/cma.j.cn112139-20231110-00221
[8] 汪珍忠, 杨燕晨, 黄焕雷, 等. 全胸腔镜微创主动脉瓣及双瓣置换术的早期结果[J]. 中国胸心血管外科临床杂志, 2023, 30(5): 710-717. https://www.cnki.com.cn/Article/CJFDTOTAL-ZXYX202305010.htm
[9] Comas GM, Wei LM, Badhwar V. Robotic-assisted double valve surgery[J]. Ann Cardiothoracic Surg, 2022, 11(5): 543-544. doi: 10.21037/acs-2022-rmvs-79
[10] Blankenberg S, Seiffert M, Vonthein R, et al. Transcatheter or surgical treatment of aortic-valve stenosis[J]. N Engl J Med, 2024, 390(17): 1572-1583. doi: 10.1056/NEJMoa2400685
[11] Gasparovic H, Tokic T. Transcatheter aortic-valve replacement in low-risk patients at five years[J]. New Engl J Med, 2024, 390(9): 865-866. doi: 10.1056/NEJMc2314602
[12] Forrest JK, Deeb GM, Yakubov SJ, et al. 4-year outcomes of patients with aortic stenosis in the evolut low risk trial[J]. J Am Coll Cardiol, 2023, 82(22): 2163-2165. doi: 10.1016/j.jacc.2023.09.813
[13] Bowdish ME, Habib RH, Kaneko T, et al. Cardiac surgery after transcatheter aortic valve replacement: trends and outcomes[J]. Ann Thorac Surg, 2024, S0003-4975(24): 00254-00256.
[14] Stone GW, Abraham WT, Lindenfeld J, et al. Five-year follow-up after transcatheter repair of secondary mitral regurgitation[J]. New Engl J Med, 2023, 388(22): 2037-2048. doi: 10.1056/NEJMoa2300213
[15] Ahmed A, Aziz TAA, Alasaad MMR, et al. Transcatheter mitral valve implantation with tendyne system ten years since the first in-human implant a systematic review[J]. J Cardiothoracic Surg, 2023, 18(1): 315. doi: 10.1186/s13019-023-02446-4
[16] Zahr F, Song HK, Chadderdon S, et al. 1-year outcomes following transfemoral transseptal transcatheter mitral valve replacement: Intrepid TMVR Early Feasibility Study Results[J]. JACC Cardiovasc Interven, 2023, 16(23): 2868-2879. doi: 10.1016/j.jcin.2023.10.001
[17] Schneider LM, Worthley S, Nickenig G, et al. 1-year outcomes following transfemoral transseptal transcatheter mitral valve replacement: The High Life TSMVR Feasibility Study[J]. JACC Cardiovasc Interven, 2023, 16(23): 2854-2865. doi: 10.1016/j.jcin.2023.09.003
[18] Kodali S, Hahn RT, Makkar R, et al. Transfemoral tricuspid valve replacement and one-year outcomes: the TRISCEND study[J]. Euro Heart J, 2023, 44(46): 4862-4873. doi: 10.1093/eurheartj/ehad667
[19] Gerçek M, Goncharov A, Narang A, et al. Characterization of screen failures among patients evaluated for transcatheter tricuspid valve repair (TriSelect-Study)[J]. JACC Cardiovasc Interven, 2023, 16(13): 1579-1589. doi: 10.1016/j.jcin.2023.03.036
-
计量
- 文章访问数: 1425
- PDF下载数: 946
- 施引文献: 0
下载: